Stenzl A, Szmulewitz RZ, Petrylak D, Holzbeierlein J, et al. The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups. Prostate 2022 Jun 8. doi: 10.1002/pros.24396.
PMID: 35675470